T-Body is a novel, premium platform, and the relationships around it are strategic and collaborative. So instead of a fixed menu, we offer a range of licensing structures built around your program.
Shared risk, shared reward. We understand the realities of drug development, so our programs share both the risk and the upside. Through co-discovery options, back-loaded payments, and performance-based milestones, we line up our interests with yours from preclinical work through commercialization.
Adapted to your needs. No two programs are alike, and we don’t treat them that way. You can structure a deal that fits your development timeline, therapeutic area, budget, risk tolerance, and commercial goals.